SCYNEXIS, Inc. (SCYX): Price and Financial Metrics
SCYX Price/Volume Stats
| Current price | $1.12 | 52-week high | $3.07 |
| Prev. close | $1.17 | 52-week low | $0.90 |
| Day low | $1.11 | Volume | 154,200 |
| Day high | $1.17 | Avg. volume | 221,097 |
| 50-day MA | $1.14 | Dividend yield | N/A |
| 200-day MA | $1.60 | Market Cap | 42.50M |
SCYX Stock Price Chart Interactive Chart >
SCYNEXIS, Inc. (SCYX) Company Bio
SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.
SCYX Price Returns
| 1-mo | 0.00% |
| 3-mo | -5.08% |
| 6-mo | -37.08% |
| 1-year | -34.88% |
| 3-year | -74.66% |
| 5-year | -90.26% |
| YTD | -7.44% |
| 2024 | -45.74% |
| 2023 | 42.95% |
| 2022 | -74.43% |
| 2021 | -20.26% |
| 2020 | -15.93% |
Continue Researching SCYX
Want to do more research on Scynexis Inc's stock and its price? Try the links below:Scynexis Inc (SCYX) Stock Price | Nasdaq
Scynexis Inc (SCYX) Stock Quote, History and News - Yahoo Finance
Scynexis Inc (SCYX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...